Pregnancy Early Pregnancy

Evaluation of the use of Proluton-Depot (hydroxyprogesterone hexanoate) in early pregnancy

Varma TR, Morsman J

Published February 1982 International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics, 20(1), 13-17
DOI 10.1016/0020-7292(82)90039-x PMID 6126401

Abstract

This study evaluates the effect of treatment with Proluton-Depot (hydroxyprogesterone hexanoate) in early pregnancy, and the final outcome of pregnancy and fetal status. One hundred and fifty patients received intramuscular injection of Proluton-Depot from 6 weeks to 8 weeks to 16 weeks to 18 weeks gestation. The outcome of this treated group was compared with a similar number of 150 patients with similar problems, but the second group received no hormonal treatment. There was no evidence to suggest that Proluton-Depot had any adverse effect on the infant or the final outcome of pregnancy.

Topics

By this author

Related research

Pregnancy › Early Pregnancy › Progesterone Support · Therapeutics › Hormonal Agents › Progesterone and Progestins · Reproductive Endocrinology › Ovarian Hormones › Progesterone
John Morsman
Jack Morsman, J Morsman
PMID 6126401 6126401 DOI 10.1016/0020-7292(82)90039-x 10.1016/0020-7292(82)90039-x Varma et al. 1982, Varma 1982